Veru (VERU) EPS (Basic) (QoQ) (2012 - 2025)
Veru (VERU) EPS (Basic) (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.41 Bn | 130.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.41 Bn | 59.23 Bn | 1.37 Bn |
| 4 | Moderna | 57.56 Bn | 52.43 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.06 Bn | 36.96 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.95 Bn | 27.65 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.48 Bn | 9.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.31 Bn | 26.15 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.04 Bn | 26.20 Bn | - |
| 10 | Veru | 60.39 Mn | 34.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,638.06% |
| Jun 30, 2025 | 80.28% |
| Mar 31, 2025 | 99.31% |
| Dec 31, 2024 | -35,111.43% |
| Sep 30, 2024 | 103.24% |
| Jun 30, 2024 | 52.47% |
| Mar 31, 2024 | -49.38% |
| Dec 31, 2023 | 93.10% |
| Sep 30, 2023 | 36.88% |
| Jun 30, 2023 | 66.76% |
| Mar 31, 2023 | -9.92% |
| Dec 31, 2022 | 27.81% |
| Sep 30, 2022 | -142.09% |
| Jun 30, 2022 | -22.85% |
| Mar 31, 2022 | -129.95% |
| Dec 31, 2021 | -82.55% |
| Sep 30, 2021 | 23.50% |
| Jun 30, 2021 | -46.54% |
| Mar 31, 2021 | -115.36% |
| Dec 31, 2020 | 241.88% |